Immunomedics: Annual Report 2013 (Immunomedics) - Mar 23, 2014 - Anticipated patent expiry in US between 2023 and 2029; Anticipated patent expiry in EU between 2023 and 2029; Anticipated patent expiry in Japan between 2023 and 2029
Anticipated patent expiry • Non-Hodgkin's Lymphoma
|